Heart Test Laboratories, Inc. Contracts & Agreements
75 Contracts & Agreements
- Business Finance (48 contracts)
- Business Operations (1)
- Human Resources (6)
- Intellectual Property (12)
- Uncategorized (8)
- Promissory Note dated September 6, 2024 (Filed With SEC on September 10, 2024)
- Note Purchase Agreement, by and between the Company and Streeterville Capital, LLC dated September 6, 2024 (Filed With SEC on September 10, 2024)
- No. 2 Amended and Restated Secured Promissory Note by and between Heart Test Laboratories, Inc. and Front Range Ventures LLC dated August 19, 2024 (Filed With SEC on August 21, 2024)
- Amendment No. 6 to Loan and Security Agreement by and between Heart Test Laboratories, Inc. and Front Range Ventures LLC dated August 19, 2024 (Filed With SEC on August 21, 2024)
- Description of Securities (Filed With SEC on July 29, 2024)
- Warrant Amendment, dated November 16, 2023, by and between Heart Test Laboratories, Inc. and John Q. Adams (Filed With SEC on November 17, 2023)
- Warrant Amendment, dated November 16, 2023, by and between Heart Test Laboratories, Inc. and Matthews Southwest Holdings, Inc (Filed With SEC on November 17, 2023)
- Note Conversion Letter Agreement, dated November 16, 2023, by and between Heart Test Laboratories, Inc. and John Q. Adams (Filed With SEC on November 17, 2023)
- Note Conversion Letter Agreement, dated November 16, 2023, by and between Heart Test Laboratories, Inc. and Matthews Southwest Holdings, Inc (Filed With SEC on November 17, 2023)
- Amendment No. 2 to Equity Distribution Agreement dated November 17, 2023 between Heart Test Laboratories, Inc. and Maxim Group LLC (Filed With SEC on November 17, 2023)
- Amendment No. 1 to Equity Distribution Agreement dated November 9, 2023 between Heart Test Laboratories, Inc. and Maxim Group LLC (Filed With SEC on November 13, 2023)
- Amendment No. 5 to the $1M Loan and Security Agreement, dated September 29, 2023 (Filed With SEC on October 16, 2023)
- Employment Agreement by and between Heart Test Laboratories, Inc. and Danielle Watson, dated October15, 2021 (Filed With SEC on October 16, 2023)
- Form of Placement Agent Warrant (Filed With SEC on October 16, 2023)
- License: HeartBEiT: Vision Transformers improve diagnostic performance for electrocardiograms (Filed With SEC on September 21, 2023)
- Form of Pre-Funded Warrant, dated as of September 20, 2023 (Filed With SEC on September 21, 2023)
- Form of Common Stock Warrant, dated as of September 20, 2023 (Filed With SEC on September 21, 2023)
- Securities Purchase Agreement, dated as of September 20, 2023, by and between the Company and Icahn School of Medicine at Mount Sinai (Filed With SEC on September 21, 2023)
- License: Pulmonary Embolism Detection From the Electrocardiogram Using Deep Learning (Filed With SEC on September 21, 2023)
- License: Deep Learning Algorithm to Predict PVC-Related Cardiomyopathy (Filed With SEC on September 21, 2023)
- License: Deep Learning on ECGs to Derive Left and Right Ventricular Function (Filed With SEC on September 21, 2023)
- License: Prediction of right ventricular size and systolic function from the 12-lead ECG (Filed With SEC on September 21, 2023)
- License: Deep learning for electrocardiograms to identify left heart valvular dysfunction - aortic stenosis (Filed With SEC on September 21, 2023)
- License: Deep learning for electrocardiograms to identify left heart valvular dysfunction mitral regurgitation (Filed With SEC on September 21, 2023)
- License: Derivation of low Left Ventricular Ejection fraction based on a foundational vision transformer (HeartBEiT) (Filed With SEC on September 21, 2023)
- License: Diagnosis of Hypertrophic Cardiomyopathy using a model derived from a foundational vision transformer (HeartBEiT) (Filed With SEC on September 21, 2023)
- License: Diagnosis of STEMI using a model derived from a foundational vision transformer (HeartBEiT) (Filed With SEC on September 21, 2023)
- License: Electrocardiogram Deep Learning Interpretability Toolbox (Filed With SEC on September 21, 2023)
- Senior Unsecured Promissory Drawdown Loan Note, dated September 7, 2023, among Heart Test Laboratories, Inc. and Matthews Southwest Holdings, Inc (Filed With SEC on September 7, 2023)
- Form of Warrant dated September 7, 2023 (Filed With SEC on September 7, 2023)
- Amendment No. 2 License Agreement by and between Heart Test Laboratories, Inc. and The University Court of The University of Glasgow, dated March 31, 2023 (Filed With SEC on July 19, 2023)
- Description of Securities (Filed With SEC on July 19, 2023)
- Form of Lockup Agreement (Filed With SEC on June 7, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 7, 2023)
- Form of Placement Agent Warrant (Filed With SEC on June 7, 2023)
- Form of Placement Agency Agreement by and between Heart Test Laboratories, Inc. and Maxim Group LLC, as exclusive placement agent thereunder (Filed With SEC on June 7, 2023)
- Form of Amendment No. 2 to Warrant to Purchase Common Stock, dated February 3, 2023 (Filed With SEC on February 3, 2023)
- Amendment No. 4 to Loan and Security Agreement (Filed With SEC on January 24, 2023)
- Amendment No. 1 to Warrant to Purchase Common Stock, dated September 8, 2022 (Filed With SEC on September 9, 2022)
- Description of Securities of Heart Test Laboratories, Inc (Filed With SEC on July 29, 2022)
- Warrant Agent Agreement dated June 17, 2022 between Heart Test Laboratories, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on June 23, 2022)
- Representatives Warrant Agreement issued June 17, 2022 (Filed With SEC on June 23, 2022)
- Underwriting Agreement dated June 15, 2022 by and between the Company and The Benchmark Company, LLC (Filed With SEC on June 15, 2022)
- Form of Underwriters Representatives Warrant Agreement (Filed With SEC on June 10, 2022)
- Form of Underwriting Agreement (Filed With SEC on June 10, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on June 10, 2022)
- Form of Certificated Warrant (Filed With SEC on June 10, 2022)
- FRV Side Letter by and between Heart Test Laboratories, Inc. and Front Range Ventures, LLC, dated April 10, 2019 (Filed With SEC on June 6, 2022)
- $1M Loan and Security Agreement by and among Heart Test Laboratories, Inc., Front Range Ventures, LLC and John Q. Adams, Sr., dated April 24, 2020 (Filed With SEC on May 17, 2022)
- Form of Registration Rights Agreement by and among Heart Test Laboratories, Inc. and the parties listed as signatories thereto related to the Series C Preferred Stock (Filed With SEC on May 17, 2022)
- $130K Note by and between Heart Test Laboratories, Inc. and Front Range Ventures, LLC, dated August 12, 2019 (Filed With SEC on May 17, 2022)
- Exercise of Option Agreement by and between Heart Test Laboratories, Inc. and The University Court of The University of Glasgow, dated December 23, 2015 (Filed With SEC on May 17, 2022)
- Evaluation, Option and License Agreement by and between Heart Test Laboratories, Inc. and The University Court of The University of Glasgow, dated June 2, 2015 (Filed With SEC on May 17, 2022)
- Security Agreement and Pledge by and between Heart Test Laboratories, Inc. and Guangren Gary Chen, dated March 14, 2014 (Filed With SEC on May 17, 2022)
- Master Assignment by and between Heart Test Laboratories, Inc. and Guangren Gary Chen, dated January 1, 2014 (Filed With SEC on May 17, 2022)
- First Amendment of MyoVista Technology Agreement by and between Heart Test Laboratories, Inc. and Guangren Gary Chen, dated March 13, 2017 (Filed With SEC on May 17, 2022)
- MyoVista Technology Agreement, by and between Heart Test Laboratories, Inc. and Guangren Gary Chen, dated December 31, 2013 (Filed With SEC on May 17, 2022)
- Form of Investor Warrant (Filed With SEC on May 17, 2022)
- Form of $1M Lender Warrant and $1.5M Lender Warrant (Filed With SEC on May 17, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on May 17, 2022)
- Form of Bridge Warrant (Filed With SEC on May 17, 2022)
- Form of Registration Rights Agreement by and between Heart Test Laboratories, Inc. and Buyers listed as signatories thereto, dated December 22, 2021 (Filed With SEC on May 17, 2022)
- Amendment No. 1 to the $1M Loan and Security Agreement, dated September 30, 2021 (Filed With SEC on May 17, 2022)
- Amendment No. 2 to the $1M Loan and Security Agreement, dated November 3, 2021 (Filed With SEC on May 17, 2022)
- Form of $1.5M Note (Filed With SEC on May 17, 2022)
- Form of Amendment No. 1 to the Form of $1.5M Note by and among Heart Test Laboratories, Inc. and the Requisite Noteholders, dated November 2, 2021 (Filed With SEC on May 17, 2022)
- Form of Securities Purchase Agreement by and between Heart Test Laboratories, Inc. and Purchasers listed as signatories thereto, dated December 22, 2021 (Filed With SEC on May 17, 2022)
- Form of Bridge Note (Filed With SEC on May 17, 2022)
- Consulting Agreement by and between Heart Test Laboratories, Inc. and Kyngstone Limited, Inc., dated June 25, 2013 (Filed With SEC on May 17, 2022)
- Amended and Restated Employment Agreement by and between Heart Test Laboratories, Inc. and Mark Hilz, dated April 5, 2022 (Filed With SEC on May 17, 2022)
- Employment Agreement by and between Heart Test Laboratories, Inc. and Andrew Simpson, dated April 5, 2022 (Filed With SEC on May 17, 2022)
- Form of Amendment No. 3 to the $1M Loan and Security Agreement, dated May , 2022 (Filed With SEC on May 17, 2022)
- Form of Amendment No. 2 to the Form of $1.5M Note by and among Heart Test Laboratories, Inc. and the Requisite Noteholders, dated May , 2022 (Filed With SEC on May 17, 2022)
- Form of Time-Based Vesting Nonstatutory Stock Option Agreement of Heart Test Laboratories, Inc (Filed With SEC on May 17, 2022)
- Form of Performance-Based Vesting Nonstatutory Stock Option Agreement of Heart Test Laboratories, Inc (Filed With SEC on May 17, 2022)
